Issued Patents 2022
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11535615 | Heterocyclic compounds as immunomodulators | Neil Lajkiewicz, Wenqing Yao | 2022-12-27 |
| 11530218 | Spiro compounds as inhibitors of KRAS | Le Zhao, Xiaozhao Wang, Wenyu Zhu, Haolin Yin, Wenqing Yao | 2022-12-20 |
| 11472791 | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors | Joshua Hummel, Jingwei Li, Zhenwu Li, Ding-Quan Qian, Kaijiong Xiao +8 more | 2022-10-18 |
| 11465981 | Heterocyclic compounds as immunomodulators | Zhiyong Yu, Fenglei Zhang, Wenqing Yao | 2022-10-11 |
| 11459329 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Jun Pan, Jeremy Roach, Song Mei, Chunhong He, Wenqing Yao | 2022-10-04 |
| 11447494 | Tricyclic amine compounds as CDK2 inhibitors | Qinda Ye, Ken Mukai, Wenqing Yao | 2022-09-20 |
| 11440914 | Tricyclic amine compounds as CDK2 inhibitors | Qinda Ye, Neil Lajkiewicz, Ken Mukai, Wenqing Yao | 2022-09-13 |
| 11427597 | Heteroaryl amide compounds as sting activators | Neil Lajkiewicz, Wenqing Yao | 2022-08-30 |
| 11427567 | Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors | Qinda Ye, Jingwei Li, Ken Mukai, Brandon Smith, Wenqing Yao +4 more | 2022-08-30 |
| 11414433 | Heterocyclic compounds as immunomodulators | Kaijiong Xiao, Wenqing Yao | 2022-08-16 |
| 11407749 | Heterocyclic compounds as immunomodulators | Bo Shen, Jingwei Li, Zhenwu Li, Kai Liu, Fenglei Zhang +1 more | 2022-08-09 |
| 11401279 | Pyrido[3,2-d]pyrimidine compounds as immunomodulators | Jingwei Li, Wenqing Yao | 2022-08-02 |
| 11401272 | Heterocyclic compounds as LSD1 inhibitors | Chunhong He, Zhenwu Li, Wenqing Yao, Fenglei Zhang | 2022-08-02 |
| 11384083 | Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors | Alexander Sokolsky, Sarah Winterton, Wenqing Yao | 2022-07-12 |
| 11339149 | Heterocyclic compounds as immunomodulators | Jingwei Li, Wenqing Yao, Chao Qi, Ding-Quan Qian, Fenglei Zhang | 2022-05-24 |
| 11247992 | Cyclopropylamines as LSD1 inhibitors | Joel R. Courter, Chunhong He, Xiaozhao Wang, Wenqing Yao, Fenglei Zhang | 2022-02-15 |